(1 - 16 from 18
)
IMGN529 Achieves OR in 40% Heavily Pretreated DLBCL
www.adcreview.com
Study shows that IMGN529 achieves objective responses in 40% of Evaluable Patients with heavily pretreated diffuse large B-cell lymphoma or DLBCL.
sorted by relevance / date